Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 24;120(47):813-814.
doi: 10.3238/arztebl.m2023.0201.

High-Cost and High-Dose Prescriptions of Cannabis-Based Medicines

High-Cost and High-Dose Prescriptions of Cannabis-Based Medicines

Beata Hennig et al. Dtsch Arztebl Int. .
No abstract available

PubMed Disclaimer

References

    1. Eisenberg E, Morlion B, Brill S, Häuser W. Medicinal cannabis for chronic pain: the bermuda triangle of low-quality studies, countless meta-analyses and conflicting recommendations. Eur J Pain. 2022;26:1183–1185. - PMC - PubMed
    1. Haroutounian S, Gilron I, Belton J, et al. Societal issues and policy implications related to the use of cannabinoids, cannabis, and cannabis-based medicines for pain management. Pain. 2021;162(Suppl 1):110–116. - PubMed
    1. Cremer-Schaeffer P, Hennig B, Schmidt-Wolf G, Marschall U, Petzke F, Häuser W. Prescriptions of cannabinoid drugs, 2019-2022—a comparison of data from the German Federal Institute for Drugs and Medical Devices and the BARMER health insurance fund. Dtsch Arztebl Int. 2023;120:186–187. - PMC - PubMed
    1. Marschall U, L‘hoest H, Radbruch L, Häuser W. Long-term opioid therapy for chronic non-cancer pain in Germany. Eur J Pain. 2016;20:767–776. - PubMed
    1. Bialas P, Böttge-Wolpers C, Fitzcharles MA, et al. Cannabis use disorder in patients with chronic pain: overestimation and underestimation in a cross-sectional observational study in 3 German pain management centres. Pain. 2023;164:1303–1311. - PubMed

Publication types